Literature DB >> 22100286

Chlamydia-induced reactive arthritis: hidden in plain sight?

John D Carter1, Robert D Inman.   

Abstract

Reactive arthritis belongs to the group of arthritidies known as the spondyloarthritides. There are two main types of reactive arthritis: post-venereal and post-enteric. Chlamydia trachomatis is felt to be the most common cause of reactive arthritis, in general. Until recently, even the terminology for the condition itself was unclear as multiple eponyms and names have been associated with reactive arthritis. In recent years, a great deal has been learnt about the epidemiology, pathophysiology and treatment of reactive arthritis and Chlamydia-induced reactive arthritis, specifically. Prospective epidemiologic data suggest that Chlamydia-induced reactive arthritis is underdiagnosed. Other truths being actively revealed include data suggesting that the pathogen itself (i.e., Chlamydia) might play an equally important role, or perhaps even more important, than the host with disease susceptibility; asymptomatic chlamydial infections might be a common cause of ReA and the two variants of reactive arthritis might respond differently to treatment in spite of the congruent clinical presentation. However, much about this syndrome remains shrouded in mystery. Data covered in this review suggest that Chlamydia-induced reactive arthritis might be a common condition that clinicians fail to recognise. An emphasis is placed on disease awareness since viable treatment options are emerging.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22100286     DOI: 10.1016/j.berh.2011.05.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  9 in total

1.  Sexually transmitted infections among young men who have sex with men: Experiences with diagnosis, treatment, and reinfection.

Authors:  Brian A Feinstein; Trey V Dellucci; Simon Graham; Jeffrey T Parsons; Brian Mustanski
Journal:  Sex Res Social Policy       Date:  2017-12-11

2.  Shear Stress Enhances Chemokine Secretion from Chlamydia pneumoniae-infected Monocytes.

Authors:  Shankar J Evani; Shatha F Dallo; Ashlesh K Murthy; Anand K Ramasubramanian
Journal:  Cell Mol Bioeng       Date:  2013-09-01       Impact factor: 2.321

Review 3.  Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research.

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

Review 4.  Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens.

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

5.  Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis.

Authors:  Robert D Inman; Basil Chiu
Journal:  Arthritis Res Ther       Date:  2012-06-20       Impact factor: 5.156

Review 6.  Reactive arthritis: update 2018.

Authors:  A García-Kutzbach; J Chacón-Súchite; H García-Ferrer; I Iraheta
Journal:  Clin Rheumatol       Date:  2018-02-17       Impact factor: 3.650

Review 7.  A review of serological tests to assist diagnosis of reactive arthritis: critical appraisal on methodologies.

Authors:  Tamara Tuuminen; Kari Lounamo; Marjatta Leirisalo-Repo
Journal:  Front Immunol       Date:  2013-12-04       Impact factor: 7.561

Review 8.  Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature.

Authors:  Philip A Chan; Ashley Robinette; Madeline Montgomery; Alexi Almonte; Susan Cu-Uvin; John R Lonks; Kimberle C Chapin; Erna M Kojic; Erica J Hardy
Journal:  Infect Dis Obstet Gynecol       Date:  2016-06-05

9.  Prevalence of Chlamydia trachomatis Infection and Its Association with Sexual Behaviour and Alcohol Use in the Population Living in Separated and Segregated Roma Settlements in Eastern Slovakia.

Authors:  Ingrid Babinská; Monika Halánová; Zuzana Kalinová; Lenka Čechová; Lýdia Čisláková; Andrea Madarasová Gecková
Journal:  Int J Environ Res Public Health       Date:  2017-12-14       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.